Table 3.
Outcome | Staples (n=84) | Suture (n=79) | Relative Risk (95% CI) |
---|---|---|---|
Primary composite outcome* | 28 (33) | 25 (32) | 1.05 (0.68–1.64) |
Wound infection 10–21 d† | 5 (6) | 5 (6) | 0.95 (0.29–3.16) |
Wound breakdown 10–21 d† | 19 (23) | 17 (22) | 1.06 (0.60–1.89) |
Length (cm) (n, median (IQR) | 18, 7 cm (3–13) | 15, 4 cm (1–8) | |
Depth (cm) (n, median (IQR) | 12, 4.3 cm (3–5.3) | 9, 2 cm (1–3) | |
Wound breakdown 4–8 wks‡ | 21 (28) | 13 (19) | 1.51 (0.82–2.78) |
Length (cm) (n, median (IQR) | 18, 4.5 cm (3–10) | 11, 2.5 cm (1–3) | |
Adjuvant treatment received§ | 43 (52) | 40 (52) | 1.00 (0.74–1.34) |
Delay of adjuvant treatment|| | 1 (2.3) | 2 (5) | 0.47 (0.04–4.93) |
CI = confidence interval
Data are n (%) unless otherwise specified. Missing values were excluded from the denominator of the percentages.
Analyses were performed by Fisher exact test (if cell count was less than 5) or Chi-square test for categorical variables; and independent t-tests for continuous variables.
Primary composite outcome = wound breakdown and surgical site infection.
Missing data in staple group only (n=83).
Missing data. Effective sample size per group: staples (n=75) and suture (n=70).
Missing data. Effective sample size per group: staples (n=83) and suture (n=77).
For delay of adjuvant treatment, n (%) and relative risk are calculated only on patients having adjuvant therapy administrated, n=43 for staples group and n=40 for suture group.